Moseley Investment Management Inc Abb Vie Inc. Transaction History

Moseley Investment Management Inc

$245 Million
Q3 2024

A detailed history of Moseley Investment Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Moseley Investment Management Inc holds 7,763 shares of ABBV stock, worth $1.37 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

7,763

Previous 7,641 1.6%

Holding current value

$1.37 Million

Previous $1.31 Million 17.02%

% of portfolio

0.63%

Previous 0.62%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$163.84 - $199.33 $19,988 - $24,318	122 Added 1.6%	7,763 $1.53 Million
Q2 2024 Jul 16, 2024	BUY	$154.79 - $180.76 $10,525 - $12,291	68 Added 0.9%	7,641 $1.31 Million
Q1 2024 Apr 04, 2024	BUY	$159.82 - $182.1 $11,347 - $12,929	71 Added 0.95%	7,573 $1.38 Million
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $625,667 - $704,648	-4,547 Reduced 37.74%	7,502 $1.16 Million
Q3 2023 Oct 16, 2023	SELL	$133.59 - $154.65 $19,637 - $22,733	-147 Reduced 1.21%	12,049 $1.8 Million
Q2 2023 Jul 06, 2023	BUY	$132.51 - $164.9 $111,705 - $139,010	843 Added 7.43%	12,196 $1.64 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $44,829 - $51,627	310 Added 2.81%	11,353 $1.81 Million
Q4 2022 Jan 24, 2023	SELL	$138.31 - $165.87 $6,362 - $7,630	-46 Reduced 0.41%	11,043 $0
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $125,352 - $143,770	934 Added 9.2%	11,089 $1.49 Million
Q2 2022 Jul 15, 2022	BUY	$137.62 - $174.96 $45,139 - $57,386	328 Added 3.34%	10,155 $1.56 Million
Q1 2022 Apr 21, 2022	SELL	$131.98 - $163.75 $36,954 - $45,850	-280 Reduced 2.77%	9,827 $1.59 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $11,387 - $14,408	106 Added 1.06%	10,107 $1.37 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $65,329 - $74,158	614 Added 6.54%	10,001 $1.09 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $59,969 - $66,809	570 Added 6.46%	9,387 $1.06 Million
Q1 2021 Apr 19, 2021	SELL	$102.3 - $112.62 $1,534 - $1,689	-15 Reduced 0.17%	8,817 $954,000
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $77,672 - $104,866	965 Added 12.27%	8,832 $946,000
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $31,700 - $37,206	-369 Reduced 4.48%	7,867 $689,000
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $61,850 - $82,765	843 Added 11.4%	8,236 $809,000
Q1 2020 Apr 20, 2020	SELL	$64.5 - $97.79 $4,837 - $7,334	-75 Reduced 1.0%	7,393 $563,000
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $109,926 - $137,541	-1,524 Reduced 16.95%	7,468 $661,000
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $112,104 - $134,781	-1,780 Reduced 16.52%	8,992 $681,000
Q2 2019 Jul 16, 2019	BUY	$65.7 - $83.98 $205,115 - $262,185	3,122 Added 40.81%	10,772 $783,000
Q1 2019 May 09, 2019	BUY	$77.14 - $90.79 $590,121 - $694,543	7,650 New	7,650 $617,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moseley Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Moseley Investment Management Inc with notifications on news.

Account

Moseley Investment Management Inc Abb Vie Inc. Transaction History